Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
COVID-19 Patient Resource Center
Clinical Trials
Search Clinical Trials
Patient Notification System
What is Clinical Research?
Volunteering for a Clinical Trial
Understanding Informed Consent
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Clinical Trial Listings
Market Research
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
JobWatch
White Papers
Patient Education
SOPs
eCFR and Guidances
White Papers
Trial Listings
Advertise
COVID-19
iConnect
Sign In
Create Account
Sign Out
My Account
Home
» FDA Actions
Looking to read the full article? Subscribe today!
FDA Actions
April 1, 2021
New FDA Actions from Altimmune, Pfizer and TissueTech.
Upcoming Events
15
Apr
Five Telltale Signs You’re Ready for an Electronic TMF System
26
Apr
MAGI's Clinical Research vConference — Spring 2021
06
May
The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next
Featured Products
Regenerative Medicine: Steps to Accelerate Development
Clinical Trial Agreements: A Guide to Key Words and Phrases
Featured Stories
FDA, Industry Tackle Problem of Including Older Adults in Trials
National Community-Based Research Network Would Improve Reach of Trials
Sites Face Trials Bottleneck After Pandemic, But Also Opportunities
Ask the Experts: Genetic Research and IBC Oversight Requirements
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here
